对糖尿病的传统和现代表观遗传疗法的比较分析与相关的认知衰退有关
Rakesh Meher1, Rajesh Kumar Meher2, Trupti Rekha Swain3
1Department of Pharmacology, School of Pharmacy, Centurion University of Technology and Management, Balangir, 767001, Odisha, India.
Computational biology and chemistry
|October 18, 2025
概括
糖尿病相关认知衰退 (DACD) 可以通过传统和现代表观遗传疗法来管理. 整合这些方法为个性化DACD治疗策略提供了一个有希望的途径.
科学领域:
- 神经科学是一个神经科学.
- 遗传学 是一个遗传学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 糖尿病相关认知衰退 (DACD) 是一个日益严重的神经退行问题,与代谢压力,神经炎症和表观遗传变化有关.
- 了解DACD复杂的病因对于开发有效的干预措施至关重要.
研究的目的:
- 批判性地审查和比较DACD的传统和现代表观遗传治疗策略.
- 探索针对个性化DACD管理的整合模型的潜力.
主要方法:
- 从2022-2025年对证据进行全面的文献综述.
- 传统 (草药,饮食,生活方式,TCM,阿育吠陀) 和现代 (制药,CRISPR,RNA,干细胞) 表观遗传干预的比较分析.
主要成果:
- 传统方法提供了广泛,可访问和安全的表观遗传途径调制,但在标准化和验证方面面临挑战.
- 现代表观遗传策略提供有针对性的,强大的干预措施,但需要进一步研究安全性,交付,成本和道德.
结论:
- 传统和现代疗法对DACD治疗都有互补的优势.
- 综合性和个性化的治疗策略,可能会得到人工智能和道德框架的增强,对未来的DACD管理有很大的前景.
相关概念视频
01:15Diabetes: Management and Pharmacotherapy
861
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
861
01:22Alzheimer's Disease: Treatment
811
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
811